Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

GUAIFENESIN EXTENDE

Closed
SPE2DP-26-T-3351Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract encompasses the procurement of 10 business units of Guaifenesin Extended-Release Tablets, 600mg, in packaging of 500 tablets per unit, under NSN 6505-01-340-5446, delivered to Fort Stewart, Georgia, with a delivery deadline of 20 days from contract award. The item is regulated by the FDA and must comply with stringent packaging and marking standards, including compliance with Medical Marking Standard No. 1 (MMS NO. 1), which supersedes MIL-STD-129 for medical acquisitions; each unit must be sealed in protective containers and packed in commercial shipping containers suitable for safe, cost-effective transport by common carrier. A minimum shelf life of 36 months is required, with at least 31 months remaining from the date of manufacture to the date of government delivery. All packaging and preservation must adhere to MIL-STD-2073-1E, and hazardous material labeling must follow the OSHA Hazard Communication Standard (29 CFR 1910.1200) unless exempted by other federal statutes such as the FDCA or FIFRA. The contract mandates electronic invoicing via WAWF, requires current SAM.gov registration with accurate socioeconomic certifications, and includes mandatory cybersecurity compliance under NIST SP 800-171, with a current assessment required for award eligibility. The contractor must also provide hazard warning labels and Material Safety Data Sheets (MSDS) prior to award for any applicable hazardous substances. Delivery is FOB destination, with inspection and acceptance occurring at the delivery point, and no variance in quantity is permitted. The contract solicitation number is SPE2DP-26-T-3351, with responses due by May 18, 2026, via the DLA Internet Bid Board System; the final contract type remains unspecified pending award, and the contracting activity is under the Defense Logistics Agency’s Medical Supply Chain Pharm FSA. Compliance with all listed technical, quality, and regulatory requirements from the DLA Master List of Technical and Quality Requirements is mandatory for award consideration.

General Info

Procurement of 10 bottles of 600 mg guaifenesin tablets with 36-month shelf life, compliant packaging.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLDG 1509 WEST 6TH STREET, FORT STEWART, GA, 31314-5185, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3351 Medical Supply Chain

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA

Full Description

Show more
GUAIFENESIN EXTENDE
GUAIFENESIN EXTENDED-RELEASE TABLETS,600MG, 500S
U/I "BT" (500'S)
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL HAVE A SHELF LIFE OF 36 MONTHS.
NOT LESS THAN 31 MONTHS SHALL REMAIN FROM DATE OF MANUFACTURE TO DATE OF
DELIVERY TO THE GOVERNMENT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
INCLUDE R2660 OBJECT TEXT ID ST
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
SPE2DP-26-T-3351
SECTION B
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00904-6986-04 RECKITT BENCKISER LLC 0MWS8 P/N NDC63824-0008-50
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016721640 0001 BT 10.000
NSN/MATERIAL:6505013405446
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-340-5446 Quantity: 10 BT Purchase Request: 7016721640QTY: 10 Delivery: 20 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS